---
title: "National Medical Products Administration: Scientifically formulate review requirements for high-end medical devices and improve the registration review system for high-end medical devices"
description: "The National Medical Products Administration issued a notice to optimize the full lifecycle supervision of high-end medical devices, scientifically formulate review requirements, and improve the regis"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/247122212.md"
published_at: "2025-07-03T10:09:04.000Z"
---

# National Medical Products Administration: Scientifically formulate review requirements for high-end medical devices and improve the registration review system for high-end medical devices

> The National Medical Products Administration issued a notice to optimize the full lifecycle supervision of high-end medical devices, scientifically formulate review requirements, and improve the registration review system. Accelerate the revision of technical review guidelines for related products, study technical guidelines in the fields of multiple diseases and artificial intelligence, simplify the registration requirements for artificial intelligence medical devices, and explore the usage path of electronic instructions

The National Medical Products Administration issued a notice to optimize the regulatory support for the entire lifecycle of high-end medical devices to promote innovative development. It mentioned the scientific formulation of review requirements for high-end medical devices and the improvement of the registration and review system for high-end medical devices. It aims to accelerate the formulation and revision of technical review guidelines for related products such as laparoscopic surgical systems, medical magnetic resonance imaging systems, oral bone filling materials for implants, and nickel-titanium alloy vascular interventional devices. It will research and develop relevant technical guidelines or review points in the fields of multi-disease and large model artificial intelligence; simplify the registration requirements for changes in artificial intelligence medical device products with optimized algorithm performance while maintaining core algorithms; explore and improve the requirements for performance evaluation of artificial intelligence medical devices using assessment databases; simplify review requirements for the same artificial intelligence software functions registered on different platforms if the equivalence of the platforms can be demonstrated. It will study the application of technologies such as artificial intelligence and biochips in the performance and safety evaluation of biomaterials medical devices. It will revise the technical review guidelines for the registration of service life of high-end active medical devices. It will explore the paths and requirements for using electronic instructions for high-end medical devices

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 美股的 “危险信号” | 本月标普 500 指数成分股在八个交易日内下跌 7% 或以上的股票数量已经超过 100 只，直逼 2022 年美股熊市的水平。 虽然这不像新冠疫情或关税危机期间那样极端，但该指标超过 100 通常意味着更大范围的下滑，而这种情况目前还没有发 | [Link](https://longbridge.com/en/news/276185288.md) |
| 一文读懂 2026 年至今的全球市场：什么在涨？美股为何不行？这种趋势会持续吗？ | 高盛报告揭示 2026 年市场新风向：周期性资产上涨仍有空间；但 AI 等热门主题估值过高，高波动或成为未来常态；美元将持续疲软；建议警惕高估值板块，分散股票持仓、保持健康的非美敞口（包括新兴市场），以及较长期限指数波动率的做多头寸。 | [Link](https://longbridge.com/en/news/276406606.md) |
| 特朗普暗示违法征收的关税不退了，美财长称今年关税收入将 “基本保持不变” | 美国总统特朗普暗示不会退还被最高法院裁定违法的关税，预计 2026 年关税收入将保持不变。特朗普计划签署行政令，对全球商品加征 10% 进口关税，取代被推翻的关税。财长贝森特表示，政府将利用替代法律权力维持关税收入，强调国家安全和财政收入不 | [Link](https://longbridge.com/en/news/276494362.md) |
| IRhythm｜10-K：2025 财年营收 7.47 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/276388892.md) |
| Pulse Biosciences｜10-K：2025 财年营收 35 万美元 |  | [Link](https://longbridge.com/en/news/276378133.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.